In all BC patients, high expression of CD155 increased 2.21-fold the risk of relapse (95%CI:1.18-4.13, Figure 5A) and a 2.57-fold higher risk of death (95%CI:1.29-5.10, Figure 6A). This evidence concerns the gene PVR and breast cancer.